High level of carotenes in the blood is associated with lesser atherosclerotic burden

FHS
June 22, 2023
3:08 pm

A high level of carotenes in the blood is linked with a lower degree of atherosclerosis in the arteries and thus a lower risk of cardiovascular diseases.

FDA approves Ionis’ TRYNGOLZA for FCS treatment

Ionis has confirmed that the therapy will be available in the US before the end of 2024. Credit: Ionis Pharmaceuticals, Inc. The US Food and

December 20, 2024

MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry | Psychedelic Invest

VANCOUVER – MindBio Therapeutics Corp. (CSE: MBIO) (Frankfurt: WF6), (the ‘Company’ or ‘MindBio’), a clinical stage biopharma company uniquely pioneering novel treatments for psychiatric conditions using microdoses of

April 24, 2024

Genetic analysis reveals hidden causes of chronic kidney disease in adults

Chronic kidney disease (CKD) is extremely prevalent among adults, affecting over 800 million individuals worldwide.

April 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.